These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Endolymphatic hydrops perspectives 2012.
    Author: Pierce NE, Antonelli PJ.
    Journal: Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):416-9. PubMed ID: 22902416.
    Abstract:
    PURPOSE OF REVIEW: Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years. RECENT FINDINGS: Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use. SUMMARY: High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.
    [Abstract] [Full Text] [Related] [New Search]